No such message found

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: YAHOO NEWS:PSTI GRANTED KEY CELL PATENTS IN 5 COUNTRIES

Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel

Company Fortifies IP Assets in Important Markets

Pluristem Therapeutics Inc.6 hours agoGlobeNewswire

HAIFA, Israel, June 1, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced it has been granted patents covering cell manufacturing, pharmaceutical compositions and disease treatment in China, South Korea, Mexico, Russia, and Israel.

Share
New Message
Please login to post a reply